Justin Kozak, Author at Founder Shield

Life Sciences Practice Lead

Justin has been involved in risk management for over a decade with Hub International, PBC, and Founder Shield. As EVP, he supports all new clients and partners joining the Founder Shield Network. Justin thrives in building bespoke insurance programs for emerging industries, especially in the Life Sciences space. His motto is to “let challenges be your driving force.”

Intellectual Property D&O Cyber Cryptocurrency Micromobility

Articles by Justin Kozak

July 27 • Risk Management

What Is a BOR Letter or Broker of Record Letter?

What is a BOR letter? Can it help you manage your specialized insurance solutions? We have the answers — and they may surprise you!

Read Article

July 20 • Risk Management

RegTech Insurance: Risk Management for Regulation Technology

Regtech insurance is specifically designed for regulation technology companies — but what risks do regtech companies face? Let’s discuss some prominent challenges and solutions for this sector.

Read Article

June 13 • Risk Management

How Uplisting Stocks Works: From OTC to Nasdaq or NYSE

Uplisting from OTC to Nasdaq or NYSE is a significant step for late-stage companies – but how does it all unfold? Let’s discuss uplisting in detail.

Read Article

November 4 • Thought Leadership

6 Lessons Learned From Recent Crypto Lawsuits — Market News to Know

The crypto market used to be hot news for its new innovations — but now the scams and lawsuits tend to make headlines. Let review some recent cases and talk about lessons we can learn from them.

Read Article

Authored FAQs by Justin Kozak

Justin Kozak

Life Sciences Practice Lead

Articles by Justin Kozak

What Is a BOR Letter or Broker of Record Letter?

RegTech Insurance: Risk Management for Regulation Technology

How Uplisting Stocks Works: From OTC to Nasdaq or NYSE

6 Lessons Learned From Recent Crypto Lawsuits — Market News to Know

Justin Kozak In the Media

The fastest path to AI: Why mid-market modernization starts with data, not replacement

Beyond the Cuts: Understanding the Real Risks for Biotech and Medical Research

Opinion: NIH Funding Cuts Are a Blow to Biotech

Fintech Meets Banking: Navigating the Risks and Rewards of Hybrid Finance

Authored FAQs by Justin Kozak

What Coverage Enhancements Are Common For Product Liability Insurance?

What Are Common Exclusions For a Product Liability Policy?

What Is Product Liability Insurance Rated On?

Authored Definitions